Article Details
Retrieved on: 2021-08-06 12:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic® platform, today announced ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here